Literature DB >> 20719177

[Clinicopathological Research and Expression of PTEN/PI3K/Akt Signaling Pathway in Non-small Cell Lung Cancer.].

Hong Shu1, Honglan Zhang, Can Xu, Xiaodong Zhao.   

Abstract

BACKGROUND: It has been known that abnormality of PTEN/PI3K/Akt signal pathway played an important role in initiation of some malignant tumors. The aim of this study is to examine the expression and clinicopathological significance of PTEN, PI3K and Akt in non-small cell lung cancer (NSCLC).
METHODS: Expression levels of PTEN, PI3K and Akt protein were determined using immunohistochemistry S-P in 61 specimens of NSCLC with follow-up.
RESULTS: (1)The levels of PTEN protein was higher than that of control group, and levels of PI3K and Akt protein were lower than that of control group; (2)Expression of PTEN and PI3K were related to histotype, clinical stage, lymphonode metastasis and survival rate; Expression of Akt was related to clinical stage, lymphonode metastasis and survival rate; (3)The Cox Monovariable Analyses revealed that both smoking and negative expression of PTEN were the risking factors on the death of the NSCLC patients after surgery; (4)The expression of PTEN protein was negatively correlated to that of PI3K and Akt respectively, while the expression of PI3K was positively correlated to that of Akt.
CONCLUSIONS: In NSCLC, the lack of PTEN induced up-regulation of PI3K and Akt, which demonstrated that PTEN/PI3K/Akt signaling pathway contributed to the tumorigenesis and development of NSCLC. They could be used as the indicators of prognosis and targets of therapy.

Entities:  

Year:  2009        PMID: 20719177     DOI: 10.3779/j.issn.1009-3419.2009.08.11

Source DB:  PubMed          Journal:  Zhongguo Fei Ai Za Zhi        ISSN: 1009-3419


  4 in total

1.  [Bioinformatic screening of key genes controlling the development and progression of lung cancer].

Authors:  Junlong Wang; Junjie Shi; Wenzhou Liu; Yu Sun; Huafu Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-11

2.  Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.

Authors:  Shuting Li; Yanwei Shen; Mengying Wang; Jiao Yang; Meng Lv; Pan Li; Zheling Chen; Jin Yang
Journal:  Oncotarget       Date:  2017-05-09

3.  Partial PTEN deletion is linked to poor prognosis in breast cancer.

Authors:  P Lebok; V Kopperschmidt; M Kluth; C Hube-Magg; C Özden; Taskin B; K Hussein; A Mittenzwei; A Lebeau; I Witzel; L Wölber; S Mahner; F Jänicke; S Geist; P Paluchowski; C Wilke; U Heilenkötter; Ronald Simon; Guido Sauter; L Terracciano; R Krech; A von d Assen; V Müller; E Burandt
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

Review 4.  [Research progress of the relationship between tumor suppressor gene 
 PTEN and non-small cell lung cancer].

Authors:  Yanan Li; Hongwu Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.